Omeros Corp (OMER)
3.92
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
3.92
0.00 (0.00%)
After-Hours: 20:00
Omeros Research and Development Expense (TTM): 132.74M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 132.74M |
| March 31, 2024 | 117.03M |
| December 31, 2023 | 114.87M |
| September 30, 2023 | 112.53M |
| June 30, 2023 | 119.37M |
| March 31, 2023 | 113.24M |
| December 31, 2022 | 112.72M |
| September 30, 2022 | 116.50M |
| June 30, 2022 | 103.75M |
| March 31, 2022 | 110.36M |
| December 31, 2021 | 118.78M |
| September 30, 2021 | 111.70M |
| June 30, 2021 | 117.20M |
| March 31, 2021 | 111.20M |
| December 31, 2020 | 107.61M |
| September 30, 2020 | 121.58M |
| June 30, 2020 | 114.00M |
| March 31, 2020 | 108.98M |
| December 31, 2019 | 106.32M |
| September 30, 2019 | 94.56M |
| June 30, 2019 | 97.67M |
| March 31, 2019 | 97.98M |
| December 31, 2018 | 89.86M |
| September 30, 2018 | 79.80M |
| June 30, 2018 | 67.77M |
| Date | Value |
|---|---|
| March 31, 2018 | 61.50M |
| December 31, 2017 | 55.60M |
| September 30, 2017 | 52.75M |
| June 30, 2017 | 50.41M |
| March 31, 2017 | 47.50M |
| December 31, 2016 | 50.70M |
| September 30, 2016 | 53.05M |
| June 30, 2016 | 53.83M |
| March 31, 2016 | 54.50M |
| December 31, 2015 | 48.38M |
| September 30, 2015 | 45.23M |
| June 30, 2015 | 43.74M |
| March 31, 2015 | 45.25M |
| December 31, 2014 | 47.95M |
| September 30, 2014 | 46.38M |
| June 30, 2014 | 44.03M |
| March 31, 2014 | 41.19M |
| December 31, 2013 | 36.30M |
| September 30, 2013 | 35.46M |
| June 30, 2013 | 33.81M |
| March 31, 2013 | 31.80M |
| December 31, 2012 | 31.92M |
| September 30, 2012 | 31.46M |
| June 30, 2012 | 29.02M |
| March 31, 2012 | 25.54M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
94.56M
Minimum
Sep 2019
132.74M
Maximum
Jun 2024
113.25M
Average
112.98M
Median
Research and Development Expense (TTM) Benchmarks
| Harrow Inc | 9.959M |
| Amphastar Pharmaceuticals Inc | 71.78M |
| PetIQ Inc | -- |
| Alector Inc | 185.53M |
| Outset Medical Inc | 50.98M |